These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11835463)

  • 1. Life-threatening parkinsonism induced by kava-kava.
    Meseguer E; Taboada R; Sánchez V; Mena MA; Campos V; García De Yébenes J
    Mov Disord; 2002 Jan; 17(1):195-6. PubMed ID: 11835463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa can worsen tremor associated with dystonia.
    Hensman DJ; Bain PG
    Mov Disord; 2006 Oct; 21(10):1778-80. PubMed ID: 16856131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic asymmetric tremor and levodopa-responsive parkinsonism due to a vein of Galen aneurysmal malformation.
    de Souza A; Fernandes YS; Bhatkar SR; Bhonsle SK
    Parkinsonism Relat Disord; 2017 Oct; 43():122-123. PubMed ID: 28729088
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine-induced parkinsonism.
    Lima MA; Maradei S; Maranhao Filho P
    J Neurol; 2009 Apr; 256(4):674-5. PubMed ID: 19367357
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy-induced parkinsonism responsive to levodopa: an underrecognized entity.
    Chuang C; Constantino A; Balmaceda C; Eidelberg D; Frucht SJ
    Mov Disord; 2003 Mar; 18(3):328-331. PubMed ID: 12621638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly asymmetrical parkinsonism as a leading feature of adult-onset Huntington's disease.
    Wang SC; Lee-Chen GJ; Wang CK; Chen CM; Tang LM; Wu YR
    Mov Disord; 2004 Jul; 19(7):854-856. PubMed ID: 15254954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible association between exposure to n-hexane and parkinsonism.
    Vanacore N; Gasparini M; Brusa L; Meco G
    Neurol Sci; 2000 Feb; 21(1):49-52. PubMed ID: 10938202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?
    Pintér D; Forjaz MJ; Martinez-Martin P; Rodriguez-Blazquez C; Ayala A; Juhász A; Harmat M; Janszky J; Kovács N
    J Parkinsons Dis; 2020; 10(1):275-282. PubMed ID: 31868685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa responsive Parkinsonism in adults with Angelman Syndrome.
    Harbord M
    J Clin Neurosci; 2001 Sep; 8(5):421-2. PubMed ID: 11535008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of parkinsonism following liver transplantation.
    Shulman LM; Minagar A; Weiner WJ
    Neurology; 2003 Feb; 60(3):519. PubMed ID: 12578945
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic treatment of parkinsonian tremor.
    Koller WC
    Arch Neurol; 1986 Feb; 43(2):126-7. PubMed ID: 3947248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign tremulous parkinsonism.
    Josephs KA; Matsumoto JY; Ahlskog JE
    Arch Neurol; 2006 Mar; 63(3):354-7. PubMed ID: 16533962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of static tremor in Parkinsonism].
    Stern P; Catović S
    Neuropsihijatrija; 1964; 12(1-4):7-10. PubMed ID: 16305149
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathophysiology of parkinsonism due to hydrocephalus.
    Racette BA; Esper GJ; Antenor J; Black KJ; Burkey A; Moerlein SM; Videen TO; Kotagal V; Ojemann JG; Perlmutter JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1617-9. PubMed ID: 15489399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of normal pressure hydrocephalus presenting as levodopa responsive parkinsonism.
    Clough CG
    J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):234. PubMed ID: 3572441
    [No Abstract]   [Full Text] [Related]  

  • 16. Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1.
    Kabel AM; Omar MS; Alhadhrami A; Alharthi SS; Alrobaian MM
    Physiol Behav; 2018 May; 188():108-118. PubMed ID: 29410018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic improvement by levodopa treatment in a patient with vascular parkinsonism.
    Onder H
    Neurol Sci; 2019 Feb; 40(2):423-425. PubMed ID: 30302597
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbidopa/levodopa-responsive myoclonus.
    Fitzgerald DB; Drago V; Sutherland D; Heilman KM
    Mov Disord; 2007 Feb; 22(3):392-5. PubMed ID: 17216651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1984 Apr; 62(4):112-6. PubMed ID: 6737958
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled-release carbidopa/levodopa in the treatment of Parkinsonism.
    Hutton JT; Dippel RL; Bianchine JR; Strahlendorf HK; Meyer PG
    Clin Neuropharmacol; 1984; 7(2):135-9. PubMed ID: 6375861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.